|
DEL GROSSO F.-COCO S.-SCARUFFI P.-STIGLIANI S.-VALDORA F.-BENELLI
R.-SALVI S.-BOCCARDO S.-TRUINI M.-CROCE M.-FERRINI S.-LONGO L.-
TONINI G.P.
Role of CXCL13/CXCR5 crosstalk between malignant neuroblastoma
cells and Schwannian stromal cells in neuroblastic tumors.
Mol. Cancer Res. 9(7):815/823, 2011
PubMed Abstract
MORETTA L.-LOCATELLI F.-PENDE D.-SIVORI S.-FALCO M.-BOTTINO C.-
MINGARI M.C.-MORETTA A.
Human NK receptors: from the molecules to the therapy of high risk
leukemias.
FEBS Lett. 585:1563/1567, 2011
PubMed Abstract
VACCA P.-VITALE C.-MONTALDO E.-CONTE R.-CANTONI C.-FULCHERI E.-
DARRETTA V.-MORETTA L.-MINGARI M.C.
CD34+ hematopoietic precursors are present in human decidua and
differentiate into natural killer cells upon interaction with
stromal cells.
Proc. Natl. Acad. Sci. USA 108(6):2402/2407, 2011
PubMed Abstract
BARABINO S.-MONTALDO E.-SOLIGNANI F.-VALENTE C.-MINGARI M.C.-
ROLANDO M.
Immune response in the conjunctival epithelium of patients with
dry eye.
Exp. Eye Res. 91:524/529, 2010
PubMed Abstract
BENELLI R.-MONTEGHIRFO S.-VENE' R.-TOSETTI F.-FERRARI N.
The chemopreventive retinoid 4HPR impairs prostate cancer cell
migration and invasion by interfering with FAK/AKT/GSK3beta
pathway and beta catenin stability.
Mol. Cancer 9:142;1/142;13, 2010
PubMed Abstract
BONACCORSI I.-CANTONI C.-CARREGA P.-OLIVERI D.-LUI G.-CONTE R.-
NAVARRA M.-CAVALIERE R.-TRAGGIAI E.-GATTORNO M.-MARTINI A.-MINGARI
M.C.-MORETTA A.-FERLAZZO G.
The immune inhibitory receptor LAIR/1 is highly expressed by
plasmacytoid dendritic cells and acts complementary with NKp44 to
control IFN(alpha) production.
PLoS One 5(11):e15080;1/e15080;8, 2010
PubMed Abstract
FALCO M.-ROMEO E.-MARCENARO S.-MARTINI S.-VITALE M.-BOTTINO C.-
MINGARI M.C.-MORETTA L.-MORETTA A.-PENDE D.
Combined genotypic and phenotypic killer cell Ig like receptor
analyses reveal KIR2DL3 alleles displaying unexpected monoclonal
antibody reactivity: identification of the amino acid residues
critical for staining.
J. Immunol. 185:433/441, 2010
PubMed Abstract
FODOR E.-BARABINO S.-MONTALDO E.-MINGARI M.C.-ROLANDO M.
Quantitative evaluation of ocular surface inflammation in patients
with different grade of conjunctivochalasis.
Curr. Eye Res. 35(8):665/669, 2010
PubMed Abstract
GATTAZZO C.-TERAMO A.-MIORIN M.-SCQUIZZATO E.-CABRELLE A.-BALSAMO
M.-AGOSTINI C.-VENDRAME E.-FACCO M.-ALBERGONI M.-TRENTIN L.-VITALE
M.-SEMENZATO G.-ZAMBELLO R.
Lack of expression of inhibitory KIR3DL1 receptor in patients with
naturak killer cell type lymphoproliferative disease of granular lymphocytes.
Haematologica 95(10):1722/1729, 2010
PubMed Abstract
LAURENT S.-CARREGA P.-SAVERINO D.-PICCIOLI P.-CAMORIANO M.-
MORABITO A.-DOZIN B.-FONTANA V.-SIMONE R.-MORTARA L.-MINGARI M.C.-
FERLAZZO G.-PISTILLO M.P.
CTLA/4 is expressed by human monocyte derived dendritic cells and
regulates their functions.
Hum. Immunol. 71:934/941, 2010
PubMed Abstract
MONTALTO E.-MANGRAVITI S.-COSTA G.-CARREGA P.-MORANDI B.-PEZZINO
G.-BONACCORSI I.-CANCELLIERI A.-MINGARI M.C.-MESITI M.-FERLAZZO G.-
MELIOLI G.
Seroma fluid subsequent to axillary lymph node dissection for
breast cancer derives from an accumulation of afferent lymph.
Immunol. Lett. 131:67/72, 2010
PubMed Abstract
MORETTA L.-LOCATELLI F.-PENDE D.-MARCENARO E.-MINGARI M.C.-MORETTA A.
Killer Ig like receptor mediated control of natural killer cell
alloreactivity in haploidentical hematopoietic stem cell
transplantation.
Blood 117(3):764/771, 2011 - Epub Oct 1, 2010
PubMed Abstract
PIETRA G.-ROMAGNANI C.-MANZINI C.-MORETTA L.-MINGARI M.C.
The emerging role of HLA/E restricted CD8+ T lymphocytes in the
adaptive immune response to pathogens and tumors.
J. Biomed. Biotechnol. 2010:907092;1/907092;8, 2010
PubMed Abstract
RUTJENS E.-MAZZA S.-BIASSONI R.-KOOPMAN G.-UGOLOTTI E.-FOGLI M.-
DUBBES R.-COSTA P.-MINGARI M.C.-GREENWOOD E.-MORETTA L.-DE MARIA
A.-HEENEY J.
CD8+ NK cells are predominant in chimpanzees, characterized by
high NCR expression and cytokine production, and preserved in
chronic HIV/1 infection.
Eur. J. Immunol. 40:1440/1450, 2010
PubMed Abstract
VACCA P.-CANTONI C.-VITALE M.-PRATO C.-CANEGALLO F.-FENOGLIO D.-
RAGNI N.-MORETTA L.-MINGARI M.C.
Crosstalk between decidual NK and CD14+ myelomonocytic cells
results in induction of Tregs and immunosuppression.
Proc. Natl. Acad. Sci. USA 107(26):11918/11923, 2010
PubMed Abstract
VENTURA E.-SASSI F.-PARODI A.-BALZA E.-BORSI L.-CASTELLANI P.-
CARNEMOLLA B.-ZARDI L.
Alternative splicing of the angiogenesis associated extra domain B
of fibronectin regulates the accessibility of the B/C loop of the
type III repeat 8.
PLoS One 5(2):e9145;1/e9145;5, 2010
PubMed Abstract
BALSAMO M.-SCORDAMAGLIA F.-PIETRA G.-MANZINI C.-CANTONI C.-BOITANO
M.-QUEIROLO P.-VERMI W.-FACCHETTI F.-MORETTA A.-MORETTA L.-MINGARI
M.C.-VITALE M.
Melanoma associated fibroblasts modulate NK cell phenotype and
antitumor cytotoxicity.
Proc. Natl. Acad. Sci. USA 106:20847/20852, 2009
PubMed Abstract
BALSAMO M.-ZAMBELLO R.-TERAMO A.-PEDRAZZI M.-SPARATORE B.-
SCORDAMAGLIA F.-PENDE D.-MINGARI M.C.-MORETTA L.-MORETTA A.-
SEMENZATO G.-VITALE M.
Analysis of NK cell/DC interaction in NK type lymphoproliferative
disease of granular lymphocytes (LDGL): role of DNAM/1 and NKp30.
Exp. Hematol. 37:1167/1175, 2009
PubMed Abstract
BALZA E.-CARNEMOLLA B.-MORTARA L.-CASTELLANI P.-SONCINI D.-ACCOLLA
R.-BORSI L.
Therapy induced antitumor vaccination in neuroblastomas by the
combined targeting of IL/2 and TNFalpha.
Int. J. Cancer 127:101/110, 2010 - Epub Oct 29, 2009
PubMed Abstract
BALZA E.-SASSI F.-VENTURA E.-PARODI A.-FOSSATI S.-BLALOCK W.-
CARNEMOLLA B.-CASTELLANI P.-ZARDI L.-BORSI L.
A novel human fibronectin cryptic sequence unmasked by the
insertion of the angiogenesis associated extra type III domain B.
Int. J. Cancer 125:751/758, 2009
PubMed Abstract
CARREGA P.-PEZZINO G.-QUEIROLO P.-BONACCORSI I.-FALCO M.-VITA G.-
PENDE D.-MISEFARI A.-MORETTA A.-MINGARI M.C.-MORETTA L.-FERLAZZO G.
Susceptibility of human melanoma cells to autologous natural
killer (NK) cell killing: HLA related effector mechanisms and role
of unlicensed NK cells.
PLoS One 4:e8132;1/e8132;10, 2009
PubMed Abstract
DELLA CHIESA M.-FALCO M.-PAROLINI S.-BELLORA F.-PETRETTO A.-ROMEO
E.-BALSAMO M.-GAMBAROTTI M.-SCORDAMAGLIA F.-TABELLINI G.-FACCHETTI
F.-VERMI W.-BOTTINO C.-MORETTA A.-VITALE M.
GPR56 as a novel marker identifying the CD56dull CD16(+) NK cell
subset both in blood stream and in inflamed peripheral tissues.
Int. Immunol. 22:91/100, 2010 - Epub Dec 14, 2009
PubMed Abstract
DE MARIA A.-UGOLOTTI E.-RUTJENS E.-MAZZA S.-RADIC L.-FARAVELLI A.-
KOOPMAN G.-DI MARCO E.-COSTA P.-ENSOLI B.-CAFARO A.-MINGARI M.C.-
MORETTA L.-HEENEY J.-BIASSONI R.
NKp44 expression, phylogenesis and function in non human primate
NK cells.
Int. Immunol. 21:245/255, 2009
PubMed Abstract
GHIO M.-CONTINI P.-NEGRINI S.-BOERO S.-MUSSO A.-POGGI A.
Soluble HLA/I mediated secretion of TGF/beta1 by human NK cells
and consequent downregulation of antitumor cytolytic activity.
Eur. J. Immunol. 39:3459/3468, 2009
PubMed Abstract
LOCATELLI F.-PENDE D.-MACCARIO R.-MINGARI M.C.-MORETTA A.-MORETTA L.
Haploidentical hemopoietic stem cell transplantation for the
treatment of high risk leukemias: how NK cells make the difference.
Clin. Immunol. 133:171/178, 2009
PubMed Abstract
MORANDI B.-MORTARA L.-CARREGA P.-CANTONI C.-COSTA G.-ACCOLLA R.-
MINGARI M.C.-FERRINI S.-MORETTA L.-FERLAZZO G.
NK cells provide helper signal for CD8+ T cells by inducing the
expression of membrane bound IL/15 on DCs.
Int. Immunol. 21:599/606, 2009
PubMed Abstract
MORETTA L.-LOCATELLI F.-PENDE D.-MINGARI M.C.-MORETTA A.
Natural killer alloeffector responses in haploidentical
hemopoietic stem cell transplantation to treat high risk leukemias.
Tissue Antigens 75:103/109, 2010 - Epub Dec 9, 2009
PubMed Abstract
PIETRA G.-MANZINI C.-VITALE M.-BALSAMO M.-OGNIO E.-BOITANO M.-
QUEIROLO P.-MORETTA L.-MINGARI M.C.
Natural killer cells kill human melanoma cells with
characteristics of cancer stem cells.
Int. Immunol. 21:793/801, 2009
PubMed Abstract
PIETRA G.-ROMAGNANI C.-MORETTA L.-MINGARI M.C.
HLA/E and HLA/E/bound peptides: recognition by subsets of NK and T
cells.
Curr. Pharm. Des. 15:3336/3344, 2009
PubMed Abstract
SENSI M.-PIETRA G.-MOLLA A.-NICOLINI G.-VEGETTI C.-BERSANI I.-
MILLO E.-WEISS E.-MORETTA L.-MINGARI M.C.-ANICHINI A.
Peptides with dual binding specificity for HLA/A2 and HLA/E are
encoded by alternatively spliced isoforms of the antioxidant
enzyme peroxiredoxin 5.
Int. Immunol. 21:257/268, 2009
PubMed Abstract
VENTURA E.-SASSI F.-FOSSATI S.-PARODI A.-BLALOCK W.-BALZA E.-
CASTELLANI P.-BORSI L.-CARNEMOLLA B.-ZARDI L.
Use of uteroglobin for the engineering of polyvalent, polyspecific
fusion proteins.
J. Biol. Chem. 284:26646/26654, 2009
PubMed Abstract
BARBORO P.-D'ARRIGO C.-REPACI E.-BAGNASCO L.-ORECCHIA P.-
CARNEMOLLA B.-PATRONE E.-BALBI C.
Proteomic analysis of the nuclear matrix in the early stages of
rat liver carcinogenesis: identification of differentially
expressed and MAR binding proteins.
Exp. Cell Res. 315:226/239, 2009 - Epub Oct 28, 2008
PubMed Abstract
BARBORO P.-RUBAGOTTI A.-ORECCHIA P.-SPINA B.-TRUINI M.-REPACI E.-CARMIGNANI G.-ROMAGNOLI
A.-INTROINI C.-BOCCARDO F.-CARNEMOLLA B.-BALBI C.
Differential proteomic analysis of nuclear matrix in muscle invasive
bladder cancer: potential to improve diagnosis and prognosis.
Cell. Oncol. 30:13/26, 2008
PubMed Abstract
CARREGA P.-MORANDI B.-COSTA R.-FRUMENTO G.-FORTE G.-ALTAVILLA G.-RATTO G.B.-MINGARI M.C.-MORETTA L.-FERLAZZO G.
Natural killer cells infiltrating human nonsmall cell lung cancer
are enriched in CD56bright CD16- cells and display an impaired
capability to kill tumor cells.
Cancer 112:863/875, 2008
PubMed Abstract
DELLA CHIESA M.-ROMEO E.-FALCO M.-BALSAMO M.-AUGUGLIARO R.-MORETTA
L.-BOTTINO C.-MORETTA A.-VITALE M.
Evidence that the KIR2DS5 gene codes for a surface receptor
triggering natural killer cell function.
Eur. J. Immunol. 38:2284/2289, 2008
PubMed Abstract
GIULIANI M.-GIRON MICHEL J.-NEGRINI S.-VACCA P.-DURALI D.-CAIGNARD
A.-LE BOUSSE C.-CHOUAIB S.-DEVOCELLE A.-BAHRI R.-DURRBACH A.-
TAOUFIK Y.-FERRINI S.-CROCE M.-MINGARI M.C.-MORETTA L.-AZZARONE B.
Generation of a novel regulatory NK cell subset from peripheral
blood CD34+ progenitors promoted by membrane bound IL/15.
PLoS ONE 3:e2241;1/e2241;16, 2008
PubMed Abstract
PENDE D.-MARCENARO S.-FALCO M.-MARTINI S.-BERNARDO M.-MONTAGNA D.-
ROMEO E.-COGNET C.-MARTINETTI M.-MACCARIO R.-MINGARI M.C.-VIVIER
E.-MORETTA L.-LOCATELLI F.-MORETTA A.
Anti leukemia activity of alloreactive NK cells in KIR ligand
mismatched haploidentical HSCT for pediatric patients: evaluation
of the functional role of activating KIR and redefinition of
inhibitory KIR specificity.
Blood 113:3119/3129, 2009 - Epub Oct 22, 2008
PubMed Abstract
STIFANESE R.-AVERNA M.-DE TULLIO R.-SALAMINO F.-CANTONI C.-MINGARI
M.C.-PRATO C.-PONTEMOLI S.-MELLONI E.
Role of the calpain calpastatin system in the density dependent
growth arrest.
Arch. Biochem. Biophys. 479:145/152, 2008
PubMed Abstract
VACCA P.-CANTONI C.-PRATO C.-FULCHERI E.-MORETTA A.-MORETTA L.-
MINGARI M.C.
Regulatory role of NKp44, NKp46, DNAM/1 and NKG2D receptors in the
interaction between NK cells and trophoblast cells. Evidence for
divergent functional profiles of decidual versus peripheral NK
cells.
Int. Immunol. 20:1395/1405, 2008
PubMed Abstract
VITALE C.-COTTALASSO F.-MONTALDO E.-MORETTA L.-MINGARI M.C.
Methylprednisolone induces preferential and rapid differentiation
of CD34+ cord blood precursors toward NK cells.
Int. Immunol. 20:565/575, 2008
PubMed Abstract
AVIGNOLO C.-BAGNASCO L.-BIASOTTI B.-MELCHIORI A.-TOMATI V.-BAUER I.-SALIS A.-CHIOSSONE
L.-MINGARI M.C.-ORECCHIA P.-CARNEMOLLA B.-NERI D.-ZARDI L.-PARODI S.
Internalization via Antennapedia protein transduction domain of an scFv
antibody toward c/Myc protein.
FASEB J. 22:1237/1245, 2008 - Epub Nov 29, 2007
PubMed Abstract
CASTRICONI R.-DONDERO A.-NEGRI F.-BELLORA F.-NOZZA P.-CARNEMOLLA B.-RASO A.-MORETTA L.-MORETTA A.-BOTTINO C.
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK mediated
cytotoxicity.
Eur. J. Immunol. 37:3190/3196, 2007
PubMed Abstract
CHIOSSONE L.-VITALE C.-COTTALASSO F.-MORETTI S.-AZZARONE B.-MORETTA L.-MINGARI M.C.
Molecular analysis of the methylprednisolone mediated inhibition of NK cell function: evidence for different susceptibility of IL/2
versus IL/15 activated NK cells.
Blood 109:3767/3775, 2007
PubMed Abstract
DE MARIA A.-FOGLI M.-MAZZA S.-BASSO M.-PICCIOTTO A.-COSTA P.-CONGIA S.-MINGARI M.C.-MORETTA L.
Increased natural cytotoxicity receptor expression and relevant IL/10 production in NK cells from chronically infected viremic HCV patients.
Eur. J. Immunol. 37:445/455, 2007
PubMed Abstract
MILLO E.-PIETRA G.-ARMIROTTI A.-VACCA P.-MINGARI M.C.-MORETTA L.-DAMONTE G.
Purification and HPLC/MS analysis of a naturally processed HCMV derived peptide isolated from the HEK/293T/HLA/E+/UL40+ cell
transfectants and presented at the cell surface in the context of HLA/E.
J. Immunol. Methods 322:128/136, 2007
PubMed Abstract
MORTARA L.-BALZA E.-SASSI F.-CASTELLANI P.-CARNEMOLLA B.-DE LERMA A.-FOSSATI
S.-TOSI G.-ACCOLLA R.-BORSI L.
Therapy induced antitumor vaccination by targeting tumor necrosis factor/alpha
to tumor vessels in combination with melphalan.
Eur. J. Immunol. 37:3381/3392, 2007
PubMed Abstract
PETRILLO G.-MARIGGIO' M.-AIELLO C.-CORDAZZO C.-FENOGLIO C.-MORGANTI S.-CROCE
M.-RIZZATO E.-SPINELLI D.-MACCAGNO M.-BIANCHI L.-PREVOSTO C.-TAVANI C.-VIALE M.
Design, synthesis, and in vitro evaluation of new naphthylnitrobutadienes
with potential antiproliferative activity: toward a structure/activity
correlation.
Bioorg. Med. Chem. 16:240/247, 2008 - Epub Sep 26, 2007
PubMed Abstract
POGGI A.-PREVOSTO C.-ZANCOLLI M.-CANEVALI P.-MUSSO A.-ZOCCHI M.
NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self antigen presenting cells and
stromal cells.
Ann. N.Y. Acad. Sci. 1109:47/57, 2007
PubMed Abstract
PREVOSTO C.-ZANCOLLI M.-CANEVALI P.-ZOCCHI M.-POGGI A.
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell
lymphocyte interaction.
Haematologica 92:881/888, 2007
PubMed
Abstract
ROMAGNANI C.-JUELKE K.-FALCO M.-MORANDI B.-D'AGOSTINO A.-COSTA R.-RATTO G.-FORTE G.-CARREGA P.-LUI G.-CONTE R.-STROWIG T.-MORETTA A.-
MUNZ C.-THIEL A.-MORETTA L.-FERLAZZO G.
CD56brightCD16- killer Ig/like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
J. Immunol. 178:4947/4955, 2007
PubMed Abstract
RUTJENS E.-MAZZA S.-BIASSONI R.-KOOPMAN G.-RADIC L.-FOGLI
M.-COSTA P.-MINGARI M.C.-MORETTA L.-HEENEY J.-DE MARIA A.
Differential NKp30 inducibility in Chimpanzee NK cells and conserved NK
cell phenotype and function in long term HIV/1
infected animals.
J. Immunol. 178:1702/1712, 2007
PubMed Abstract
SCORDAMAGLIA F.-BALSAMO M.-SCORDAMAGLIA A.-MORETTA A.-MINGARI M.C.-CANONICA G.-MORETTA
L.-VITALE M.
Perturbations of natural killer cell regulatory functions in respiratory
allergic diseases.
J. Allergy Clin. Immunol. 121:479/485, 2008 - Epub Nov 30, 2007
PubMed Abstract
SPAGGIARI G.-CAPOBIANCO A.-ABDELRAZIK H.-BECCHETTI F.-MINGARI M.C.-MORETTA L.
Mesenchymal stem cells inhibit natural killer cell proliferation,
cytotoxicity and cytokine production: role of indoleamine
2,3/dioxygenase and prostaglandin E2.
Blood 111:1327/1333, 2008 - Epub Oct 19, 2007
PubMed Abstract
VIALE M.-PETRILLO G.-AIELLO C.-FENOGLIO C.-CORDAZZO C.-MARIGGIO'
M.-CASSANO A.-PREVOSTO C.-OGNIO E.-MACCAGNO M.-BIANCHI L.-VACCARONE R.-RIZZATO E.-SPINELLI
D.
Synthesis, in vitro activity and in vivo toxicity of the new 2,3-dinitrobutadiene
derivative (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene.
Pharmacol. Res. 56:318/328, 2007
PubMed Abstract
BALZA E.-MORTARA L.-SASSI F.-MONTEGHIRFO S.-CARNEMOLLA B.-CASTELLANI P.-NERI D.-ACCOLLA R.-ZARDI L.-BORSI L.
Targeted delivery of tumor necrosis factor alpha to tumor vessels induces a therapeutic T cell mediated immune response that
protects the host against syngeneic tumors of different histologic origin.
Clin. Cancer Res. 12:2575/2581, 2006
PubMed Abstract
DELLA CHIESA M.-CARLOMAGNO S.-FRUMENTO G.-BALSAMO M.-CANTONI C.-CONTE R.-MORETTA L.-MORETTA A.-VITALE M.
The tryptophan catabolite L/kynurenine inhibits the surface expression of NKp46 and NKG2D activating receptors and regulates NK cell function.
Blood 108:4118/4125, 2006
PubMed Abstract
MARCENARO S.-GALLO F.-MARTINI S.-SANTORO A.-GRIFFITHS G.-ARICO' M.-MORETTA L.-PENDE D.
Analysis of natural killer cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface
expression heralds Munc13/4 defect and discriminates between genetic subtypes of the disease.
Blood 108:2316/2323, 2006
PubMed Abstract
MORETTA L.-BOTTINO C.-PENDE D.-CASTRICONI R.-MINGARI M.C.-MORETTA A.
Surface NK receptors and their ligands on tumor cells.
Semin. Immunol. 18:151/158, 2006
PubMed Abstract
MORETTA L.-FERLAZZO G.-BOTTINO C.-VITALE M.-PENDE D.-MINGARI M.C.-MORETTA A.
Effector and regulatory events during natural killer dendritic cell interactions.
Immunol. Rev. 214:219/228, 2006
PubMed Abstract
PENDE D.-CASTRICONI R.-ROMAGNANI P.-SPAGGIARI G.-MARCENARO S.-DONDERO A.-LAZZERI E.-LASAGNI L.-MARTINI S.-RIVERA P.-CAPOBIANCO A.-
MORETTA L.-MORETTA A.-BOTTINO C.
Expression of the DNAM/1 ligands, nectin/2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for
natural killer dendritic cell interaction.
Blood 107:2030/2036, 2006
PubMed Abstract
SPAGGIARI G.-CAPOBIANCO A.-BECCHETTI S.-MINGARI M.C.-MORETTA L.
Mesenchymal stem cell natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs,
whereas MSCs can inhibit IL/2 induced NK cell proliferation.
Blood 107:1484/1490, 2006
PubMed Abstract
STIFANESE R.-AVERNA M.-SALAMINO F.-CANTONI C.-MINGARI M.C.-PRATO C.-PONTREMOLI S.-MELLONI E.
Characterization of the calpain/calpastatin system in human hemopoietic cell lines.
Arch. Biochem. Biophys. 456:48/57, 2006
PubMed Abstract
VACCA P.-PIETRA G.-FALCO M.-ROMEO E.-BOTTINO C.-BELLORA F.-PREFUMO F.-FULCHERI E.-VENTURINI P.-COSTA M.-MORETTA A.-MORETTA L.-MINGARI M.C.
Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function.
Blood 108:4078/4085, 2006
PubMed Abstract
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura